Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
4.
Osaka Daigaku Shigaku Zasshi ; 35(1): 328-32, 1990 Jun.
Article in Japanese | MEDLINE | ID: mdl-2135411

ABSTRACT

The coccal form as well as the L form of Staphylococcus aureus could produce the metabolic and growth inhibiting antibodies of the L form in the rabbit sera.


Subject(s)
Antibodies, Bacterial/biosynthesis , Immunoglobulins/immunology , Staphylococcus aureus/immunology , Animals , L Forms/immunology , Rabbits , Staphylococcus aureus/metabolism
5.
Osaka Daigaku Shigaku Zasshi ; 35(1): 333-41, 1990 Jun.
Article in Japanese | MEDLINE | ID: mdl-2135412

ABSTRACT

Metabolic and growth inhibiting activities in immunoglobulin (of anti-S. aureus L-form serum and anti-S. aureus coccal form serum) could be absorbed by cell membranes of S. aureus L-form and its coccal form, respectively. These activities could not be absorbed by cell membrane of Micrococcus luteus, Streptococcus pyogenes or Actinomyces viscosus. These findings suggested the existence of species-specific antigens of cell membrane. The membrane antigens of L-form related to the metabolic and growth inhibiting activities were stable to trypsin, heating and periodate, and were not solubilized by trypsin. A large part of the antigen in a typsin-insoluble membrane precipitate of L-form could be extracted by acetone and the subsequent use of chloroform-methanol (2: 1). A fractionation study of chloroform-methanol extract by using silicic acid calum indicated that more than two components were involved in metabolic and growth inhibiting activities.


Subject(s)
Antigens, Bacterial/immunology , Bacterial Outer Membrane Proteins/immunology , Immunoglobulins/immunology , Staphylococcus aureus/immunology , Antibodies, Bacterial/immunology , L Forms/immunology , Species Specificity , Staphylococcus aureus/metabolism
6.
Infect Immun ; 57(11): 3372-6, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2478472

ABSTRACT

A gene encoding a Streptococcus mutans surface protein antigen has been isolated from a strain GS-5 gene bank constructed via the Streptococcus-Escherichia coli shuttle vector pSA3. This E. coli recombinant clone, designated 4B2, expressed S. mutans proteins, as shown by Western immunoblot analysis with a specific rabbit antibody to S. mutans surface antigens. Three bands were observed, including a 52-kilodalton (kDa) protein (pI 5.7), a 29-kDa protein (pI 4.2), and a 20-kDa protein usually present in lower amounts. The 52- and 29-kDa proteins both reacted with a monoclonal antibody to S. mutans antigen A, a 29-kDa protein which has been characterized and used as a vaccine for the prevention of induced caries in rodents and monkeys. The 52-kDa protein, but not the 29-kDa protein, showed a capacity to bind to a broad number of carbohydrate polymers. The results from this study suggest that the recombinant 4B2 clone specifies a 52-kDa protein which is a precursor to the 29-kDa antigen A.


Subject(s)
Antigens, Bacterial/genetics , Genes, Bacterial , Streptococcus mutans/genetics , Antibodies, Bacterial/immunology , Antibodies, Monoclonal/immunology , Antigens, Bacterial/metabolism , Bacterial Adhesion , Bacterial Proteins/genetics , Bacterial Proteins/immunology , Bacterial Proteins/metabolism , Bacterial Vaccines , Blotting, Western , Cloning, Molecular , DNA, Bacterial/genetics , Dextrans/metabolism , Isoelectric Point , Molecular Weight , Restriction Mapping , Streptococcus mutans/immunology , Streptococcus mutans/pathogenicity , Vaccines, Synthetic
8.
Biken J ; 29(2): 39-44, 1986 Jun.
Article in English | MEDLINE | ID: mdl-3814073

ABSTRACT

The experimental conditions under which protoplasts of Staphylococcus aureus strain MS353 (pCp) are converted to the coccal or L-form were investigated. Protoplasts prepared by treating coccal MS353 (pCp) strain with Lysostaphin formed various types of colonies (coccal form, L-form and mixed types) in about 50% yield when they were plated on reversion (R) medium consisting of 2% brain heart infusion, 0.5M sodium succinate, 0.01% bovine serum albumin, 20 mM MgCl2 and 0.6% agar. The L-form type colonies with a typical fried-egg appearance that developed on the R medium at an early stage gradually reverted to the coccal form through a mixed type stage in which a high density area first appeared in the periphery of the colony and then spread throughout the colony. The use of modified R medium without MgCl2 or R medium in which 0.5M sodium succinate as an osmotic stabilizer was replaced by 7.5% NaCl resulted in marked delay in the appearance of reverted cells. R medium without bovine serum albumin yielded atypical L-form type colonies, which contained masses of coccal cells with very irregular margins. On the other hand, R medium without MgCl2 but with penicillin G supported development of L-form type colonies at high rate (13-15%) from the inoculated protoplasts.


Subject(s)
L Forms/cytology , Lysostaphin/pharmacology , Protoplasts/physiology , Staphylococcus aureus/cytology , Culture Media , L Forms/growth & development , Magnesium/metabolism , Magnesium Chloride , Serum Albumin, Bovine/metabolism , Staphylococcus aureus/growth & development
9.
Biken J ; 29(2): 45-9, 1986 Jun.
Article in English | MEDLINE | ID: mdl-2949736

ABSTRACT

Streptomycin (SM)- or erythromycin (EM)-resistant lysogenic and non-lysogenic substrains were produced from two Staphylococcus aureus L-form strains lysogenic for different prophages, namely, EMT-L (prophage alpha) and 209P (prophage beta). Cells of these L-form substrains were fused in various combinations using polyethylene glycol (PEG), and the frequency of recombinants selected as double resistance to both SM and EM and the prophage types of these recombinants were examined. In all the combinations, the frequency of recombinants was greater when the cells were treated with PEG than when they were not, and the difference was statistically significant (p less than 0.01) in 13 combinations. Combination between the lysogenic SM-resistant EMT-L substrain [EMT(Smr-alpha)] and lysogenic EM-resistant 209P-L substrain [209P(Emr-beta)] and the reverse combination, between 209P(Smr-beta) and EMT(Emr-alpha), resulted in a majority of recombinants harboring prophage beta. The former combination yielded recombinants that all held both prophage alpha and beta.


Subject(s)
L Forms/physiology , Lysogeny , Recombination, Genetic , Staphylococcus aureus/physiology , Bacteriolysis , Bacteriophage Typing , Drug Resistance, Microbial , Erythromycin/pharmacology , L Forms/genetics , Polyethylene Glycols/pharmacology , Staphylococcus Phages/physiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , Streptomycin/pharmacology
11.
Biken J ; 28(3-4): 59-70, 1985 Dec.
Article in English | MEDLINE | ID: mdl-3834926

ABSTRACT

Mixtures of various combinations of Lysostaphin protoplasts and stable L-forms of Staphylococcus aureus, which have different markers for drug resistance, were treated with polyethylene glycol (PEG) to examine the development of doubly resistant fusion products (fusants). To recover doubly resistant colonies as L-forms, they were incubated in 4.5% NaCl-brain heart infusion (BHI) broth containing penicillin G (PCG) for enrichment culture and cultured in PCG-4.5% NaCl-BHI agar medium (method 1), while to recover doubly resistant fusants as L-forms and coccal forms, they were grown on reversion medium (R medium) which causes reversion of protoplasts or fusants to parent type cells, and then cultured on assay media, i.e., R medium, BHI agar medium or PCG-4.5% NaCl-BHI agar medium (method 2). Under both experimental conditions, doubly resistant fusants developed as L-form cells by PEG treatment of pairs of protoplasts carrying the chloramphenicol (CP)-resistance plasmid and L-forms having chromosomal resistance to streptomycin (SM). In the reverse combinations, i.e., protoplasts showing chromosomal SM-resistance and L-form cells carrying the CP-resistance plasmid, the first method gave no doubly resistant colonies. By the second method, without enrichment culture on R medium, the latter combination gave doubly resistant fusants as L-form, coccal-type and mixed-type colonial forms, while when the PEG-treated mixture was enriched on R medium, fusants were obtained exclusively as the coccal type on either R medium or BHI agar assay medium. Neither of the methods yielded colonies of doubly resistant fusants on PEG-treatment of pairs of protoplasts and L-forms both of which were chromosomal, but with different drug resistances. These results show that PEG-induced cell fusion between protoplasts and L-forms of S. aureus, unlike the fusion between protoplasts or between L-forms, resulted in transfer of the drug resistance controlled by the plasmid to the fusion products. The fusants obtained were L-forms in method 1, and coccal type in the method 2.


Subject(s)
Protoplasts/physiology , Staphylococcus aureus/genetics , Adhesiveness , Cells, Cultured , Chloramphenicol/pharmacology , L Forms/genetics , Lysostaphin , Plasmids/drug effects , Polyethylene Glycols/pharmacology , Protoplasts/drug effects , Staphylococcus aureus/drug effects , Staphylococcus aureus/physiology , Streptomycin/pharmacology
15.
Biken J ; 26(3): 103-11, 1983 Sep.
Article in English | MEDLINE | ID: mdl-6426458

ABSTRACT

Intergenus cell fusion of prokaryotic bacteria was demonstrated for the first time; namely, fusion products doubly resistant to streptomycin and tetracycline were produced by polyethylene glycol treatment of a mixture of the streptomycin-resistant L-form of Pseudomonas aeruginosa and tetracycline-resistant L-form of Escherichia coli.


Subject(s)
Cell Fusion , Escherichia coli/physiology , Pseudomonas aeruginosa/physiology , Drug Resistance, Microbial , Polyethylene Glycols , Species Specificity , Streptomycin/pharmacology , Tetracycline/pharmacology
16.
Infect Immun ; 37(3): 1181-90, 1982 Sep.
Article in English | MEDLINE | ID: mdl-7129634

ABSTRACT

A study was made on the activity of various bacterial cell walls and peptidoglycans to liberate serotonin from rabbit blood platelets. All of the test cell walls or peptidoglycans prepared from 27 strains of 21 bacterial species were shown to cause a marked release of serotonin, regardless of differences in types of peptidoglycan and non-peptidoglycan moieties and in some biological properties. The assay made with the water-soluble "digests" of Staphylococcus epidermidis cell wall peptidoglycans, which were prepared by use of appropriate enzymes, revealed that a polymer of peptidoglycan subunits (a disaccharide-stempeptide) was definitely active in the release of serotonin, but a structural unit monomer was inactive. Among a variety of synthetic muramylpeptides and their 6-O-acyl derivatives, only 6-O-(3-hydroxy-2-docosylhexacosanoyl)-N-acetylmuramyl-L-alanyl-D-isoglutaminyl- L-lysyl-D-alanine was found to hold a strong serotonin-liberating activity.


Subject(s)
Blood Platelets/physiology , Cell Wall/physiology , Peptidoglycan/pharmacology , Serotonin/blood , Acetylmuramyl-Alanyl-Isoglutamine/pharmacology , Animals , Bacteria/ultrastructure , Chemical Phenomena , Chemistry , Rabbits , Staphylococcus/analysis , Structure-Activity Relationship
17.
Biken J ; 25(3): 111-9, 1982 Sep.
Article in English | MEDLINE | ID: mdl-7165686

ABSTRACT

Various combinations of four substrains of Staphylococcus aureus L-form (strain STA-EMT-1), each of which was resistant to one of the following four drugs, streptomycin (SM), tetracycline (TC), chloramphenicol (CP) and erythromycin (EM), were submitted to polyethylene glycol (PEG)-induced cell fusion. PEG-induced cell fusion followed by enrichment culture in the liquid basal medium supplemented with penicillin G resulted in development of recombinants that were doubly drug-resistant to SM and TC, SM and CP, and TC and CP, but no recombinant doubly resistant to EM and TC, was obtained by treatment of a EM-resistant and TC-resistant substrains with PEG. No recombinants resistant to SM, CP and TC could be obtained by treatment of substrains resistant to SM, CP and TC, respectively, with PEG. But recombinants triply resistant to these three drugs were produced by two-step cell fusion; that is by fusion of a recombinant doubly resistant to two of the three drugs with a substrain resistant to the third drug.


Subject(s)
Chloramphenicol/pharmacology , Mutation , Staphylococcus aureus/genetics , Streptomycin/pharmacology , Tetracycline/pharmacology , Drug Resistance, Microbial , Erythromycin/pharmacology , Polyethylene Glycols , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification
18.
Microbiol Immunol ; 25(3): 317-26, 1981.
Article in English | MEDLINE | ID: mdl-6973057

ABSTRACT

The cytoplasmic membranes and a cytoplasmic fraction of Staphylococcus aureus L-forms increased the incorporation of [3H]thymidine by human lymphocytes in the presence of fetal bovine serum. Both fractions stimulated cord blood lymphocytes as well as adult peripheral lymphocytes, suggesting the possibility that the observed effect was not due to an antigen-specific reaction, but to an immunologically nonspecific action. The membrane mitogen(s) was resistant to trypsin, although it was partially solubilized by trypsin treatment. The mitogen(s) could not be extracted with a chloroform-methanol mixture (2:1, v/v), although the chloroform-methanol soluble fraction was strongly mitogenic to murine splenocytes. Human serum which was added to the assay system in place of fetal bovine serum definitely suppressed the mitogenic effect of both cytoplasmic membranes and the cytoplasmic fraction, especially the latter.


Subject(s)
Cytoplasm/microbiology , L Forms , Lymphocytes/microbiology , Mitogens/pharmacology , Staphylococcus aureus/cytology , Humans , Interleukin-2/antagonists & inhibitors , Intracellular Membranes , Spinal Cord/blood supply , Staphylococcus aureus/classification , Subcellular Fractions/physiology , Time Factors
19.
Biken J ; 23(1): 43-8, 1980 Mar.
Article in English | MEDLINE | ID: mdl-7437004

ABSTRACT

Further evidence is presented that on treatment with polyethylene glycol the emergence of doubly drug-resistant recombinants of Staphylococcus aureus L-forms from substrains resistant to streptomycin or erythromycin only is really due to cell fusion, and not to other genetic transfer mechanisms. The reason for the necessity of enrichment culture is also discussed.


Subject(s)
L Forms/genetics , Recombination, Genetic , Staphylococcus aureus/genetics , Drug Resistance, Microbial , Erythromycin/pharmacology , L Forms/physiology , Polyethylene Glycols/pharmacology , Staphylococcus aureus/physiology , Streptomycin/pharmacology
20.
Microbiol Immunol ; 24(11): 1079-90, 1980.
Article in English | MEDLINE | ID: mdl-7219205

ABSTRACT

Cytoplasmic membranes of L-forms of Staphylococcus aureus exerted a strong mitogenic effect on splenocytes of athymic nude mice as well as normal mice, while a cytoplasmic fraction of the same bacteria did not show definite mitogenicity. The mitogenic principle(s) of the membrane fraction was resistant to treatment with trypsin and was heat stable (at 100 C for 10 min). The active principle(s) in the insoluble residue of the membrane fraction digested with trypsin was not extracted with cold acetone, but could be solubilized by extraction with a cold chloroform-methanol mixture (2:1, v/v). The mitogenic principle(s) in the extract was fractionated by silicic acid column chromatography. Among five fractions separated by chromatography, fractions eluted with chloroform-methanol mixtures (1:1 and 1:20, v/v) were found to be strongly mitogenic. The cytoplasmic membranes of the L-forms also exerted a definite mitogenic effect on guinea pig splenocytes, but not on the thymocytes.


Subject(s)
Cell Membrane/analysis , L Forms/analysis , Mitogens , Staphylococcus aureus/analysis , Animals , Cells, Cultured , Guinea Pigs , Mice , Mitosis , Spleen/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...